https://www.selleckchem.com/pr....oducts/mpp-dihydroch
rograms, empowering VHCs, CBHVs and CHAs to realize success. The effects of oral antihyperglycaemic drugs (OADs) for type 2 diabetes mellitus (T2DM) on the outcomes of co-existing chronic obstructive pulmonary disease (COPD) patients are not well studied. We examined the association of combinational OADs and the risk of acute exacerbations of COPD (AECOPD) in T2DM patients with co-existing COPD. A cohort-based case-control study was conducted using data from the National Health Insurance Research Database of Taiwan. Among ne
Like
Comment
Share
